Advanced search
Publication Cover
Expert Review of Anti-infective Therapy Volume 20, 2022 - Issue 11
Submit an article Journal homepage
1,089
Views
4
CrossRef citations to date
0
Altmetric
Review

Treatment strategies for OXA-48-like and NDM producing Klebsiella pneumoniae infections

Burcu Islera University of Queensland, Faculty of Medicine, UQ Centre for Clinical Research, Brisbane, Australia;b Infection Management Services, Princess Alexandra Hospital, Brisbane, AustraliaCorrespondence[email protected]
View further author information
,
Abdullah Tarık Aslanc Department of Internal Medicine, Golhisar State Hospital, 15100Golhisar, TurkeyView further author information
,
Murat Akovad Infectious Diseases and Clinical Microbiology, Hacettepe University School of Medicine, AnkaraView further author information
,
Patrick Harrisa University of Queensland, Faculty of Medicine, UQ Centre for Clinical Research, Brisbane, AustraliaView further author information
&
David L. Patersona University of Queensland, Faculty of Medicine, UQ Centre for Clinical Research, Brisbane, Australia;e Saw Swee Hock School of Public Health, National University of Singapore, SingaporeView further author information
Pages 1389-1400 | Received 29 Jun 2022, Accepted 22 Sep 2022, Published online: 28 Sep 2022

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Burcu Isler, Cansel Vatansever, Berna Özer, Güle Çınar, Abdullah Tarık Aslan, Caitlin Falconer, Michelle J. Bauer, Brian Forde, Funda Şimşek, Necla Tülek, Hamiyet Demirkaya, Şirin Menekşe, Halis Akalin, İlker İnanç Balkan, Mehtap Aydın, Elif Tükenmez Tigen, Safiye Koçulu Demir, Mahir Kapmaz, Şiran Keske, Özlem Doğan, Çiğdem Arabacı, Serap Yağcı, Gülşen Hazırolan, Veli Oğuzalp Bakır, Mehmet Gönen, Neşe Saltoğlu, Alpay Azap, Özlem Azap, Murat Akova, Önder Ergönül, Füsun Can, David L. Paterson & Patrick N. A. Harris. (2023) Higher rates of cefiderocol resistance among NDM producing Klebsiella bloodstream isolates applying EUCAST over CLSI breakpoints. Infectious Diseases 55:9, pages 607-613.
Read now

Articles from other publishers (3)

Mirco Sandfort, Jörg B Hans, Martin A Fischer, Felix Reichert, Martina Cremanns, Jessica Eisfeld, Yvonne Pfeifer, Annika Heck, Tim Eckmanns, Guido Werner, Sören Gatermann, Sebastian Haller & Niels Pfennigwerth. (2022) Increase in NDM-1 and NDM-1/OXA-48-producing Klebsiella pneumoniae in Germany associated with the war in Ukraine, 2022. Eurosurveillance 27:50.
Crossref
Abdullah Tarık Aslan, Murat Akova & David L. Paterson. (2022) Next-Generation Polymyxin Class of Antibiotics: A Ray of Hope Illuminating a Dark Road. Antibiotics 11:12, pages 1711.
Crossref
N.E. BarantsevichElena P. Barantsevich. (2022) Antimicrobial therapy of sepsis caused by carbapenem-resistant Klebsiella pneumoniae in patients with hematological malignancies. Clinical Microbiology and Antimicrobial Chemotherapy 24:4, pages 383-387.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.